Literature DB >> 20216227

The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance.

Bruno Pinamonti1, Marco Merlo, René Nangah, Renata Korcova, Andrea Di Lenarda, Giulia Barbati, Gianfranco Sinagra.   

Abstract

OBJECTIVES: The significance of the progression of systolic and diastolic dysfunctions in hypertrophic cardiomyopathy (HCM) is still an open issue. We sought to evaluate the clinical and prognostic implications of the progression of left ventricular systolic and diastolic dysfunction in HCM.
METHODS: One hundred one HCM patients were studied by echo-Doppler at baseline and during follow-up.
RESULTS: During a follow-up of 109 + or - 67 months, 28% of patients showed a progression to left ventricular diastolic dysfunction, defined as restrictive filling pattern (RFP), and 16% to left ventricular systolic dysfunction (left ventricular ejection fraction <50%). The 10-year heart transplant-free survival rate was 45% in patients with RFP at follow-up vs. 82% in the patients without RFP (P < 0.001), and 52% in patients with left ventricular systolic dysfunction at follow-up vs. 75% in the patients with left ventricular ejection fraction of at least 50% (P = 0.001). Baseline predictors of death/transplantation were New York Heart Association class III-IV, indexed left atrial diameter, and RFP. When RFP and left ventricular systolic dysfunction were added at follow-up, both emerged as prognostic predictors (RFP: hazard ratio 8.92, 95% confidence interval 2.5-31.86; systolic dysfunction: hazard ratio 25.35, 95% confidence interval 3.57-179.88) with a significant increase of area under the receiver-operating characteristic curves (0.81 vs. 0.70, P = 0.03) with respect to the baseline model.
CONCLUSION: Left ventricular diastolic and/or systolic dysfunction at follow-up are relatively frequent in HCM and are associated with a poor prognosis.

Entities:  

Mesh:

Year:  2010        PMID: 20216227     DOI: 10.2459/JCM.0b013e3283383355

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  3 in total

1.  How does morphology impact on diastolic function in hypertrophic cardiomyopathy? A single centre experience.

Authors:  Gherardo Finocchiaro; Francois Haddad; Aleksandra Pavlovic; Emma Magavern; Gianfranco Sinagra; Joshua W Knowles; Jonathan Myers; Euan A Ashley
Journal:  BMJ Open       Date:  2014-06-12       Impact factor: 2.692

2.  Dysregulation of proangiogeneic factors in pressure-overload left-ventricular hypertrophy results in inadequate capillary growth.

Authors:  Mohamed Zeriouh; Anton Sabashnikov; Arne Tenbrock; Klaus Neef; Julia Merkle; Kaveh Eghbalzadeh; Carolyn Weber; Oliver J Liakopoulos; Antje-Christin Deppe; Christof Stamm; Douglas B Cowan; Thorsten Wahlers; Yeong-Hoon Choi
Journal:  Ther Adv Cardiovasc Dis       Date:  2019 Jan-Dec

3.  Association of NT-proBNP and hs-cTnT with Imaging Markers of Diastolic Dysfunction and Focal Myocardial Fibrosis in Hypertrophic Cardiomyopathy.

Authors:  Céleste Chevalier; Miriam Wendner; Anna Suling; Ersin Cavus; Kai Muellerleile; Gunnar Lund; Paulus Kirchhof; Monica Patten
Journal:  Life (Basel)       Date:  2022-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.